COVID 19 Memos
Categories
Financial Reporting in Light of COVID-19: Statement from the SEC’s Office of the Chief Accountant (June 24, 2020)
Swiftly Accessing Capital Markets in Uncertain Times (June 4, 2020)
Corporate Governance Update: EESG and the COVID-19 Crisis (May 28, 2020)
Reopening to a New Normal: Considerations for Boards (May 18, 2020)
Update on COVID-19 Impacts on Landlords of Retail Debtors (May 18, 2020)
Creating Liquidity during the COVID-19 Pandemic: Convertible Bonds (May 13, 2020)
Top 10 Tax Issues in the COVID-19 Downturn (May 11, 2020)
Nasdaq Adopts Temporary COVID-19 Exception to Shareholder Approval Rules (May 8, 2020)
Managing Human Resources in a Challenging Economic Environment (May 7, 2020)
“New” IRS Guidance Provides Relief from Dividend Payment Requirement for REITs (May 6, 2020)
Lessons From the Future – The First Contested Virtual Annual Meeting (May 6, 2020)
REITs and COVID-19: 15 Key Issues for Boards as They Chart the Course Forward (April 28, 2020)
What to Say on Your Next Earnings Call in the Time of COVID-19: Providing Insights, Disclosing Scenarios and Managing Risks (April 20, 2020)
COVID-19 Impacts on Landlords of Retail Debtors (April 13, 2020)
Key ESG Considerations In the Crisis (April 13, 2020)
ISS Issues Guidance Regarding COVID-19 Pandemic (April 9, 2020)
Activist Attacks and Firm Value (April 9, 2020)
Federal Reserve Unveils Main Street Lending Program (April 9, 2020)
Delaware Court of Chancery Rejects Challenge to CEO Separation Agreement (April 8, 2020)
NYSE Temporarily Relaxes Shareholder Approval Rules (April 8, 2020)
What to Say on Your Next Earnings Call in the Time of COVID-19 – SEC Chairman Jay Clayton and CorpFin Director Bill Hinman Lead the Way (April 8, 2020)
White Collar and Regulatory Enforcement in the Era of COVID-19 (April 6, 2020)
REIT M&A and Activism: Preparing for Threats in the COVID-19 Environment (April 6, 2020)
Governance Litigation and the COVID-19 Pandemic (April 3, 2020)
Compensation Limits on Corporate Participants in CARES Act Programs (April 2, 2020)
Rights Plans (“Poison Pills”) in the COVID-19 Environment – “On the Shelf and Ready to Go”? (April 1, 2020)
Fiduciary Duties in Times of Financial Distress (April 1, 2020)
Emergency Changes to Australian Foreign Investment Laws Continue Global Trend of Extending Reviews of Transactions (April 1, 2020)
Activists Will Show Their True Colors in COVID-19 Pandemic (March 31, 2020)
The CARES Act: Litigation and Enforcement Lessons from the Financial Crisis (March 30, 2020)
Preserving Liquidity during the COVID-19 Pandemic (March 30, 2020)
The CARES Act Expands the Charitable Contribution Deduction (March 29, 2020)
Congress Passes CARES Act (March 27, 2020)
Merger Control in the Current Crisis (March 27, 2020)
Corporate Governance Update: Director Oversight in the Context of COVID-19 (March 26, 2020)
Disclosure in the Time of COVID-19 – Guidance from the Division of Corporation Finance (March 26, 2020)
Financial Institutions Developments – Stimulus Bill Authorizes FDIC Guarantee of Bank Debt and Unlimited Deposit Insurance of Transaction Accounts (March 26, 2020)
The Crisis and the Activist and Raiders (March 25, 2020)
Government Stimulus Funding: Planning Ahead by Looking Back (March 24, 2020)
Controlling Material, Non-Public Information During the Coronavirus Pandemic (March 24, 2020)
Litigation Priorities and the Crisis (March 23, 2020)
Disclosure Issues Relating to COVID-19 (March 20, 2020)
Debt Covenant Compliance and the COVID-19 Pandemic (March 20, 2020)
Regulators Around the World Address Short Selling in Response to the COVID-19 Market Crisis (March 19, 2020)
BlackRock Announces New KPIs for Public Companies, Tougher Director Votes and Continued High Expectations During COVID-19 Pandemic (March 18, 2020)
COVID-19: What Compensation Committees Should Be Thinking About Today (March 18, 2020)
Key Issues for Directors Relating to COVID-19 (March 17, 2020)
Corporate Liquidity and the COVID-19 Pandemic (March 17, 2020)